Cale, Jessica M.
Ham, Kristin A.
Li, Dunhui
McIntosh, Craig S.
Watts, Gerald F.
Wilton, Steve D.
Aung-Htut, May T.
Funding for this research was provided by:
Murdoch University
Perron Institute for Neurological and Translational Science
Royal Perth Hospital
University of Western Australia
Article History
Received: 5 June 2023
Accepted: 7 November 2023
First Online: 13 November 2023
Competing interests
: S.D.W. and M.T.A.-H are consultants to Sarepta Therapeutics; S.D.W. is a named inventor on patents licensed through the University of Western Australia to Sarepta Therapeutics and as such is entitled to milestone and royalty payments; K.A.H., C.S.M., M.T.A.-H., receive salary support from Sarepta Therapeutics. G.F.W. has received financial support for lectures, advisory boards or research from Arrowhead, Amgen, Pfizer, Sanofi, Regeneron, Novartis, AstraZeneca, Silence Therapeutics and Esperion. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results. J.M.C. and D.L. declare no competing interests.